(Q43768859)

26 November 2017

title

Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease (English)

1 reference

26 November 2017

1 reference

K Abe

1

1 reference

26 November 2017

K Taguchi

2

1 reference

26 November 2017

T Wasai

3

1 reference

26 November 2017

J Ren

4

1 reference

26 November 2017

I Utsunomiya

5

1 reference

26 November 2017

T Shinohara

6

1 reference

26 November 2017

T Miyatake

7

1 reference

26 November 2017

T Sano

8

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

published in

Brain Research Bulletin

1 reference

26 November 2017

volume

56

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

55-60

1 reference

Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Possible extrapyramidal system degradation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in an experimental model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Effects of new endogenous nonprotein amino acids, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives, on behavior of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

The endogenous amine 1-methyl-1,2,3,4- tetrahydroisoquinoline prevents the inhibition of complex I of the respiratory chain produced by MPP(+)

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

(-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900603-7

7 January 2021

10.1016/S0361-9230(01)00603-7

Identifiers

DOI

1 reference

26 November 2017

1 reference